Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.
about
Effect of Ginkgo biloba extract on the expressions of Cox-2 and GST-Pi in rats with hepatocellular carcinoma riskInflammation to cancer: The molecular biology in the pancreas (Review).Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinomaA randomized, placebo-controlled, multicenter, biomarker-selected, phase 2 study of apricoxib in combination with erlotinib in patients with advanced non-small-cell lung cancer.Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy.Prognostic significance of cyclooxygenase-2 protein in pancreatic cancer: a meta-analysis.Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.COX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells.Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant PathwayRisk factors and therapeutic targets in pancreatic cancer.Brief overview of selected approaches in targeting pancreatic adenocarcinoma.New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.Knockdown delta-5-desaturase promotes the formation of a novel free radical byproduct from COX-catalyzed ω-6 peroxidation to induce apoptosis and sensitize pancreatic cancer cells to chemotherapy drugs.Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice.Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cellsDevelopment of a nanoliposomal formulation of erlotinib for lung cancer and in vitro/in vivo antitumoral evaluation.Activity cliffs and activity cliff generators based on chemotype-related activity landscapes.Organocatalytic multicomponent synthesis of polysubstituted pyrroles from 1,2-diones, aldehydes and arylamines.
P2860
Q28646415-DD38101E-4411-48F7-8927-F16C560FC488Q33727657-3FB22358-3A29-467A-817A-DD50D48F3977Q34246014-6CD7AC05-CB47-42D1-A79F-4B6DB5EEBF71Q34743106-6EF43BC2-16C0-4D40-8DB7-6E108CB5A452Q35165488-BB3014B5-C289-464B-95AA-B2B42E3E2756Q35208554-F3485823-FD4A-49B7-A162-22B1F38C2577Q35550185-BDF6655D-F35C-4FA0-B9BD-60318BA0604EQ36110362-EA7B3E4F-AF25-4AA7-9426-8B6D7050F397Q36218965-59C29597-4DAB-446A-B260-EE5718D1BC57Q37317310-7E10C9A3-11C9-4ECE-B3D8-F605676C4551Q38199723-70D972B6-366B-43FC-91C2-26DCF54AD477Q38550876-6D93B5AC-AE88-42B0-9BA4-B9F2FBEFED8FQ38760434-BCE959A2-0783-47A4-AE4F-4EA7EC8568F7Q41565207-D0CD33A8-DEBA-4160-BCA9-29149E2460CCQ42199704-86D09A8B-4363-4BE5-867B-42E7D82AB45EQ47138585-633AC476-0F38-41F2-AFAC-3D6C7E19978DQ48161808-A13AD246-5804-4668-B838-B68EA6FB243BQ51700860-B8D8ABBD-77B6-43DE-A7B2-6D352E3BF59E
P2860
Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Apricoxib, a novel inhibitor o ...... d models of pancreatic cancer.
@ast
Apricoxib, a novel inhibitor o ...... d models of pancreatic cancer.
@en
Apricoxib, a novel inhibitor o ...... d models of pancreatic cancer.
@nl
type
label
Apricoxib, a novel inhibitor o ...... d models of pancreatic cancer.
@ast
Apricoxib, a novel inhibitor o ...... d models of pancreatic cancer.
@en
Apricoxib, a novel inhibitor o ...... d models of pancreatic cancer.
@nl
prefLabel
Apricoxib, a novel inhibitor o ...... d models of pancreatic cancer.
@ast
Apricoxib, a novel inhibitor o ...... d models of pancreatic cancer.
@en
Apricoxib, a novel inhibitor o ...... d models of pancreatic cancer.
@nl
P2093
P2860
P1476
Apricoxib, a novel inhibitor o ...... d models of pancreatic cancer.
@en
P2093
Amanda Kirane
Francis J Burrows
Jason E Toombs
Jordan Braunfeld
Juliet G Carbon
Katherine Ostapoff
Roderich E Schwarz
Rolf A Brekken
Sara Zaknoen
P2860
P304
P356
10.1158/1078-0432.CCR-12-0453
P407
P577
2012-07-24T00:00:00Z